Back to top
more

Dr. Reddys Laboratories (RDY)

(Delayed Data from NYSE)

$81.43 USD

81.43
157,016

-1.89 (-2.27%)

Updated Aug 14, 2024 04:00 PM ET

After-Market: $81.45 +0.02 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 10% (26 out of 250)

Industry: Medical - Generic Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies

by Zacks Equity Research

Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies are part of the Zacks Industry Outlook article.

Sundeep Ganoria headshot

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

by Sundeep Ganoria

The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, AMPH and SLGL.

Dr. Reddy's (RDY) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Dr. Reddy's (RDY) reports better-than-expected fiscal second-quarter 2024 results where both earnings and revenues beat estimates, driven by growth in core businesses in North America and Europe.

All You Need to Know About Doctor Reddy's (RDY) Rating Upgrade to Strong Buy

by Zacks Equity Research

Doctor Reddy's (RDY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks.com featured highlights Marathon Oil, Dr. Reddy's Laboratories, American Eagle, Peabody Energy and Skechers USA

by Zacks Equity Research

Marathon Oil, Dr. Reddy's Laboratories, American Eagle, Peabody Energy and Skechers USA have been highlighted in this Screen of The Week article.

Nilanjan Choudhury headshot

5 Top-Ranked Stocks With Compelling Relative Price Strength

by Nilanjan Choudhury

MRO. RDY, AEO, BTU and SKX are five stocks with explosive relative price strength.

Here's Why Doctor Reddy's (RDY) is a Strong Growth Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

3 Reasons Growth Investors Will Love Doctor Reddy's (RDY)

by Zacks Equity Research

Doctor Reddy's (RDY) could produce exceptional returns because of its solid growth attributes.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Analyst Blog Highlights Molina Healthcare, Dr. Reddy's Laboratories and NeuroBo Pharmaceuticals

by Zacks Equity Research

Molina Healthcare, Dr. Reddy's Laboratories and NeuroBo Pharmaceuticals are part of the Zacks top Analyst Blog.

Indrajit Bandyopadhyay headshot

Protect Your Portfolio From Volatility With 3 Low-Beta Picks

by Indrajit Bandyopadhyay

At this stage, it is prudent to invest in low-beta stocks with a favorable Zacks Rank like ALC, RDY and ANIK, as these will be less volatile than the broader market.

Indrajit Bandyopadhyay headshot

Want to Shrug Off Volatility? Buy 3 Medical Growth Stocks

by Indrajit Bandyopadhyay

We pick three medical stocks - MOH, RDY and NRBO - that have gained more than 5% in the past three months amid market volatility.

Doctor Reddy's (RDY) Loses -6.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

by Zacks Equity Research

Doctor Reddy's (RDY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Why Doctor Reddy's (RDY) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Strength Seen in Bausch (BHC): Can Its 8.0% Jump Turn into More Strength?

by Zacks Equity Research

Bausch (BHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Derek Lewis headshot

Navigate Volatility With These 3 Low-Beta Stocks

by Derek Lewis

Low-beta stocks can provide many beneficial advantages for investors, including a more defensive nature and overall portfolio balance.

Ethan Feller headshot

Discount Alert: 3 Top Ranked Stocks Trading Below Historical Valuations

by Ethan Feller

While the headlines often spotlight stocks that are soaring to new heights, some of the best investment prospects lie in stocks trading below their historical valuations

Here is Why Growth Investors Should Buy Doctor Reddy's (RDY) Now

by Zacks Equity Research

Doctor Reddy's (RDY) could produce exceptional returns because of its solid growth attributes.

Zacks.com featured highlights Caterpillar, KB Home, Walmart, Dr. Reddy's Laboratories and FedEx

by Zacks Equity Research

Caterpillar, KB Home, Walmart, Dr. Reddy's Laboratories and FedEx have been highlighted in this Screen of The Week article.

Sweta Killa headshot

5 Dividend Growth Stocks for Steady Returns in Uncertain Times

by Sweta Killa

Caterpillar (CAT), KB Home (KBH), Walmart (WMT), Dr. Reddy's (RDY) and FedEx (FDX) could be solid choices amid the current market volatility.

Derek Lewis headshot

These 3 Low-Beta Stocks Sport High Growth

by Derek Lewis

Low-beta stocks can provide many beneficial advantages for investors, including a more defensive nature and overall portfolio balance. And for those seeking this approach, these three stocks are great considerations.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Looking for a Growth Stock? 3 Reasons Why Doctor Reddy's (RDY) is a Solid Choice

by Zacks Equity Research

Doctor Reddy's (RDY) could produce exceptional returns because of its solid growth attributes.